Bicara Therapeutics (BCAX) EBT (2023 - 2026)
Bicara Therapeutics (BCAX) posted quarterly EBT of -$56.2 million for Q1 2026, down 52.71% year-over-year from -$118.8 million in Q1 2025, and down 50.43% quarter-over-quarter from -$37.3 million in Q4 2025.
Bicara Therapeutics (BCAX) EBT (2023 - 2026) Analysis & Trends
Bicara Therapeutics' EBT history runs 4 years deep, the most recent figure standing at -$56.2 million for Q1 2026.
- In Q1 2026, EBT fell 52.71% year-over-year to -$56.2 million; the TTM figure through Mar 2026 stood at -$157.1 million (down 70.64% YoY), while the FY2025 annual figure was -$137.7 million, down 103.12% from the prior year.
- EBT for Q1 2026 stood at -$56.2 million, down from -$37.3 million in the prior quarter.
- The five-year high for EBT was -$12.4 million in Q4 2023, with the low at -$56.2 million in Q1 2026.
- The 4-year median for EBT is -$22.8 million (2023), against an average of -$27.0 million.
- The sharpest annual moves came in 2024 and 2025: EBT grew 23.48% in 2024, then sank 194.03% in 2025.
- Bicara Therapeutics' EBT stood at -$12.4 million in 2023, then plunged by 67.04% to -$20.8 million in 2024, then tumbled by 79.74% to -$37.3 million in 2025, then tumbled by 50.43% to -$56.2 million in 2026.
- Business Quant data shows BCAX's EBT at -$56.2 million in Q1 2026, -$37.3 million in Q4 2025, and -$36.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.39 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.53 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 541.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -644.37 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 312.46 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -2,828.29 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 81.49 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 177.81 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -11.37 Mn |
| 10 | Bicara Therapeutics | 1.60 Bn | 1.60 Bn | - | -55.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -55.38 Mn |
| Mar 31, 2026 | -56.16 Mn |
| Dec 31, 2025 | -37.33 Mn |
| Sep 30, 2025 | -36.29 Mn |
| Jun 30, 2025 | -27.34 Mn |
| Mar 31, 2025 | -36.77 Mn |
| Dec 31, 2024 | -20.77 Mn |
| Sep 30, 2024 | -17.48 Mn |
| Jun 30, 2024 | -17.05 Mn |
| Mar 31, 2024 | -12.51 Mn |
| Dec 31, 2023 | -12.44 Mn |
| Sep 30, 2023 | -22.85 Mn |